According to the World Health Organization (WHO), 235 million people suffer from asthma worldwide.

To

Ingress-health B.V. and Indivumed GmbH announced today the launch of an exclusive partnership on real-world evidence (RWE) studies in

Lung cancer is the leading cause of cancer-associated mortality worldwide, with non-small cell lung cancer (NSCLC) accounting for a majority

World Cancer Day empowers everyone around the world to show support, raise our collective voice and take action. We, at

Ingress-health is constantly eager to explore methods and frameworks for conducting patient preference research. In a recent study, the impact

This month, Ingress-health team participated in 2 posters being presented at the Transplantation & Cellular Therapy (TCT) Meetings of ASBMT

On Monday, the International Epilepsy Day promoted awareness about the 50 million people living with epilepsy worldwide. To commemorate this

It is cervical cancer awareness prevention week in the UK. Did you know that Ingress-health is strongly focused on conducting

ABQ-HIV: a unique questionnaire for identifying potential risk factors associated with medication related non-adherence for HIV-patients
Non-adherence to medication is

Meet us at ISPOR Europe 2018, in Barcelona (10-14 November)!
That time of the year has come again, when the